The Intuitive Surgical Inc (ISRG) share price is expected to increase by 0.52% over the next year. This is based on calculating the average 12-month share price estimate provided by 17 stock analysts who have covered ISRG. Price targets range from $443 at the low end to $604 at the high end. The current analyst consensus for ISRG is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Intuitive Surgical Inc has a total of 17 Wall St Analyst ratings. There are 11 buy ratings, 5 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Intuitive Surgical Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of ISRG.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
David Rescott Baird | Outperform | $565 | Maintains | Oct 18, 2024 |
Ryan Zimmerman BTIG | Buy | $535 | Maintains | Oct 18, 2024 |
Vijay Kumar Evercore ISI Group | In-Line | $490 | Maintains | Oct 18, 2024 |
Adam Maeder Piper Sandler | Overweight | $538 | Reiterates | Oct 18, 2024 |
Rick Wise Stifel | Buy | $525 | Maintains | Oct 18, 2024 |
Shagun Singh RBC Capital | Outperform | $555 | Maintains | Oct 18, 2024 |
Larry Biegelsen Wells Fargo | Overweight | $549 | Maintains | Oct 18, 2024 |
Richard Newitter Truist Securities | Buy | $570 | Maintains | Oct 14, 2024 |
Ryan Zimmerman BTIG | Buy | $518 | Maintains | Oct 14, 2024 |
Jayson Bedford Raymond James | Outperform | $540 | Maintains | Oct 14, 2024 |
Robbie Marcus JP Morgan | Overweight | $575 | Maintains | Oct 11, 2024 |
Shagun Singh RBC Capital | Outperform | $525 | Maintains | Oct 8, 2024 |
Vijay Kumar Evercore ISI Group | In-Line | $475 | Maintains | Oct 1, 2024 |
Ryan Zimmerman BTIG | Buy | $494 | Maintains | Aug 28, 2024 |
Joanne Wuensch Citigroup | Buy | $560 | Maintains | Aug 22, 2024 |
Ed Ridley-Day Redburn Atlantic | Buy | $510 | Upgrade | Aug 2, 2024 |
Matt Miksic Barclays | Overweight | $510 | Maintains | Jul 23, 2024 |
Vijay Kumar Evercore ISI Group | In-Line | $410 | Maintains | Jul 19, 2024 |
Cecilia Furlong Morgan Stanley | Equal-Weight | $475 | Maintains | Jul 19, 2024 |
Sterling Auty JP Morgan | Overweight | $495 | Maintains | Jul 19, 2024 |
When did it IPO
2000
Staff Count
13,676
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Dr. Gary S. Guthart Ph.D.
Market Cap
$191.07B
In 2023, ISRG generated $7.12B in revenue, which was a increase of 14.49% from the previous year. This can be seen as a signal that ISRG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Analyst recommendations from brokerage firms significantly influence stock prices, impacting investor decisions on buying, selling, or holding stocks.
Why It Matters - Analyst recommendations can significantly sway stock prices, impacting investment decisions and market sentiment, highlighting their influence on trading strategies and portfolio performance.
Summary - Certain stocks have performed well this year, suggesting potential for long-term investment over the next two decades or more.
Why It Matters - Long-term potential indicates sustained growth, suggesting stability and profitability. This could attract long-term investors seeking reliable returns over time.
Summary - Benzinga's Stock Whisper Index highlights five under-the-radar stocks weekly, utilizing proprietary data and pattern recognition for investor consideration.
Why It Matters - The Stock Whisper Index highlights potential undervalued stocks, offering investors insights into emerging opportunities that may lead to significant returns.
Summary - Zacks.com users are increasingly focused on Intuitive Surgical (ISRG), indicating potential investor interest.
Why It Matters - Increased attention on Intuitive Surgical (ISRG) may signal potential stock movement, impacting trading strategies and investment decisions.
Summary - A list of health-related buy-and-hold stocks is available, featuring market leaders in healthcare with sustainable growth, strong balance sheets, and broad market support.
Why It Matters - The excerpt highlights strong healthcare stocks with sustainable growth and solid financials, signaling potential for stable, long-term investment returns.
Summary - Intuitive Surgical (NASDAQ: ISRG) is expected to grow its value nearly 10x in the long run, driven by advancements in its robotic surgical business, similar to Nvidia's recent stock performance.
Why It Matters - Intuitive Surgical's potential for significant growth in the robotic surgical market could lead to substantial returns, drawing parallels to Nvidia's success in AI, indicating strong investment opportunities.